Owner Allergan, Inc.

Inventors Im, Wha Bin; Donde, Yariv; Holoboski, Mark; Old, David W.; Kedzie, Karen M.; Gil, Daniel W.; Donello, John E.; Burk, Robert M.; Gac, Todd S.

Agent Davies Collison Cave

Pub. Number AU-B-2005299473

PCT Pub. Number WO2006/047476

Priority 60/622,422 26.10.04 US

Filing date 24 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 28 June 2012

C07C 405/00 Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/557 - Eicosanoids, e.g. leukotrienes

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates